X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3469) 3469
Publication (446) 446
Newsletter (18) 18
Book Review (14) 14
Book Chapter (13) 13
Book / eBook (8) 8
Conference Proceeding (6) 6
Magazine Article (3) 3
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2764) 2764
male (1339) 1339
female (1275) 1275
index medicus (1242) 1242
animals (1073) 1073
hematology (983) 983
polycythemia-vera (948) 948
middle aged (826) 826
adult (809) 809
polycythemia (667) 667
mice (658) 658
mutation (647) 647
aged (641) 641
essential thrombocythemia (526) 526
janus kinase 2 - genetics (503) 503
myeloproliferative disorders (432) 432
oncology (414) 414
janus kinase 2 - metabolism (361) 361
polycythemia - blood (360) 360
polycythemia - metabolism (337) 337
tyrosine kinase jak2 (336) 336
polycythemia - etiology (335) 335
hematocrit (333) 333
erythropoiesis (330) 330
polycythemia vera (307) 307
polycythemia vera - blood (293) 293
polycythemia vera - genetics (269) 269
erythropoietin (265) 265
myeloproliferative disorders - genetics (256) 256
aged, 80 and over (253) 253
iron - metabolism (250) 250
polycythemia vera - metabolism (248) 248
signal transduction (244) 244
erythrocytes - metabolism (239) 239
myelofibrosis (238) 238
hemic and lymphatic diseases (235) 235
rats (231) 231
polycythemia - genetics (230) 230
myeloproliferative neoplasms (217) 217
research (216) 216
erythropoietin - metabolism (210) 210
expression (206) 206
jak2 (205) 205
leukemia (202) 202
hypoxia (201) 201
adolescent (193) 193
genetic aspects (189) 189
cell biology (187) 187
biochemistry & molecular biology (182) 182
medicine, research & experimental (181) 181
myeloproliferative disorders - metabolism (179) 179
abridged index medicus (178) 178
hemoglobins - metabolism (177) 177
polycythemia vera - pathology (173) 173
article (171) 171
polycythemia - physiopathology (166) 166
iron isotopes (163) 163
janus kinase 2 - antagonists & inhibitors (158) 158
cancer (155) 155
bone marrow - metabolism (154) 154
erythrocytosis (152) 152
erythropoietin - biosynthesis (152) 152
tumors (152) 152
erythropoietin - blood (151) 151
myeloid metaplasia (151) 151
janus kinase 2 (147) 147
thrombocythemia, essential - genetics (147) 147
disease (145) 145
phosphorylation (143) 143
analysis (142) 142
erythropoietin - pharmacology (142) 142
diagnosis (141) 141
anemia (140) 140
cells (137) 137
myeloproliferative disorders - pathology (137) 137
risk factors (137) 137
cells, cultured (136) 136
polycythemia - complications (136) 136
time factors (133) 133
gene expression (132) 132
primary myelofibrosis - genetics (132) 132
blood (131) 131
medicine, general & internal (127) 127
physiological aspects (127) 127
primary myelofibrosis (125) 125
thrombosis (125) 125
activation (124) 124
chronic disease (123) 123
erythropoiesis - drug effects (122) 122
polycythemia vera - complications (122) 122
oxygen - metabolism (121) 121
case-control studies (120) 120
amino acid substitution (118) 118
bone marrow (116) 116
bone marrow cells (115) 115
care and treatment (114) 114
disorders (114) 114
polycythemia vera - diagnosis (114) 114
cell line, tumor (113) 113
pathology (113) 113
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3224) 3224
German (62) 62
Russian (61) 61
French (33) 33
Japanese (32) 32
Polish (22) 22
Italian (17) 17
Spanish (13) 13
Chinese (11) 11
Hungarian (7) 7
Korean (3) 3
Turkish (3) 3
Czech (2) 2
Norwegian (2) 2
Portuguese (2) 2
Ukrainian (2) 2
Afrikaans (1) 1
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Romanian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 02/2017, Volume 129, Issue 6, pp. 667 - 679
The genetic landscape of classicalmyelopro-liferative neoplasm (MPN) is in large part elucidated. The MPN-restricted driver mutations, including those in JAK2,... 
POLYCYTHEMIA-VERA | LEUKEMIC TRANSFORMATION | ACTIVATING MUTATION | CLONAL HEMATOPOIESIS | MUTANT CALRETICULIN | ACQUIRED UNIPARENTAL DISOMY | ESSENTIAL THROMBOCYTHEMIA | HEMATOLOGY | SOMATIC MUTATIONS | THROMBOPOIETIN RECEPTOR | HEMATOPOIETIC STEM | Thrombocythemia, Essential - physiopathology | Epigenesis, Genetic | Humans | Gene Expression Regulation, Neoplastic | STAT Transcription Factors - metabolism | Polycythemia Vera - genetics | Receptors, Granulocyte Colony-Stimulating Factor - genetics | Thrombocythemia, Essential - genetics | Calreticulin - genetics | Receptors, Erythropoietin - genetics | DNA (Cytosine-5-)-Methyltransferases - metabolism | DNA-Binding Proteins - metabolism | Polycythemia Vera - metabolism | Janus Kinase 2 - metabolism | Calreticulin - metabolism | Receptors, Granulocyte Colony-Stimulating Factor - metabolism | Polycythemia Vera - physiopathology | Primary Myelofibrosis - metabolism | Repressor Proteins - metabolism | Proto-Oncogene Proteins - metabolism | Enhancer of Zeste Homolog 2 Protein - genetics | Enhancer of Zeste Homolog 2 Protein - metabolism | Primary Myelofibrosis - physiopathology | Janus Kinase 2 - genetics | Repressor Proteins - genetics | Proto-Oncogene Proteins - genetics | DNA-Binding Proteins - genetics | Receptors, Thrombopoietin - metabolism | Disease Progression | DNA (Cytosine-5-)-Methyltransferases - genetics | Receptors, Thrombopoietin - genetics | Primary Myelofibrosis - genetics | STAT Transcription Factors - genetics | Mutation | Receptors, Erythropoietin - metabolism | Thrombocythemia, Essential - metabolism
Journal Article
Journal Article
Journal Article
Blood Reviews, ISSN 0268-960X, 2012, Volume 27, Issue 1, pp. 41 - 53
Journal Article
American Journal of Physiology - Renal Physiology, ISSN 0363-6127, 07/2010, Volume 299, Issue 1, pp. F1 - F13
Haase VH. Hypoxic regulation of erythropoiesis and iron metabolism. Am J Physiol Renal Physiol 299: F1-F13, 2010. First published May 5, 2010; doi:... 
Hypoxia-inducible factors | Hypoxia | Iron | Red blood cells | Erythropoietin | red blood cells | hypoxia | TRANSCRIPTIONAL ACTIVATION | PHYSIOLOGY | INDUCIBLE FACTOR-I | hypoxia-inducible factors | CHUVASH POLYCYTHEMIA | HYDROXYLASE DOMAIN PROTEIN-2 | FACTOR 1-ALPHA | MESSENGER-RNA | GENE-EXPRESSION | UROLOGY & NEPHROLOGY | iron | TUMOR-SUPPRESSOR | CHRONIC KIDNEY-DISEASE | erythropoietin | TRANSGENIC MICE | Polycythemia - genetics | Anemia - blood | Humans | Homeostasis | Polycythemia - blood | Erythropoiesis - drug effects | Procollagen-Proline Dioxygenase - metabolism | Erythropoietin - blood | Anemia - genetics | Kidney - metabolism | Anemia - drug therapy | Basic Helix-Loop-Helix Transcription Factors - metabolism | Bone Marrow - metabolism | Von Hippel-Lindau Tumor Suppressor Protein - genetics | Erythropoietin - biosynthesis | Erythropoiesis - genetics | Iron - blood | Basic Helix-Loop-Helix Transcription Factors - genetics | Hematinics - therapeutic use | Gene Expression Regulation | Von Hippel-Lindau Tumor Suppressor Protein - blood | Oxygen - blood | Erythrocytes - drug effects | Erythropoietin - genetics | Hypoxia - blood | Hypoxia - genetics | Animals | Procollagen-Proline Dioxygenase - genetics | Erythrocytes - metabolism | Protein Processing, Post-Translational | Erythrocytes | Cell metabolism | Development and progression | Iron in the body | Research | Properties | Observations | Biological control systems | Reviews
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 09/2016, Volume 311, Issue 3, pp. H759 - H767
Hypoxia-inducible factor (HIF) appears to function as a global master regulator of cellular and systemic responses to hypoxia. HIF pathway manipulation is of... 
Magnetic resonance imaging | Hypoxia-inducible factor | Hyperpolarized pyruvate | magnetic resonance imaging | VHLR200W MUTATION | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | CHRONIC HYPOBARIC HYPOXIA | PULMONARY ARTERIAL-HYPERTENSION | MOUSE | hyperpolarized pyruvate | hypoxia-inducible factor | MAGNETIC-RESONANCE-SPECTROSCOPY | GENE-EXPRESSION | PERIPHERAL VASCULAR DISEASE | RAT-HEART | CONGENITAL POLYCYTHEMIA | GLUCOSE-UPTAKE | L-Lactate Dehydrogenase - metabolism | Polycythemia - genetics | Carbon Isotopes | Hypertension, Pulmonary - diagnostic imaging | Tritium | Hypoxia-Inducible Factor 1, alpha Subunit | Aryl Hydrocarbon Receptor Nuclear Translocator | Adenosine Triphosphate - metabolism | Myocardium - metabolism | Polycythemia - diagnostic imaging | Hypertrophy, Right Ventricular - diagnostic imaging | Pyruvic Acid - metabolism | Von Hippel-Lindau Tumor Suppressor Protein - genetics | Hypertrophy, Right Ventricular - metabolism | Hypertrophy, Right Ventricular - genetics | Basic Helix-Loop-Helix Transcription Factors | Disease Models, Animal | Heart - physiopathology | Magnetic Resonance Spectroscopy | Isolated Heart Preparation | Hypertension, Pulmonary - genetics | Hypertension, Pulmonary - metabolism | Cardiotonic Agents - pharmacology | Polycythemia - congenital | Stroke Volume | Magnetic Resonance Imaging | Phosphates - metabolism | Animals | Isoproterenol - pharmacology | Polycythemia - metabolism | Glucose - metabolism | Glycolysis | Heart - drug effects | Mice | Phosphocreatine - metabolism | Transcription Factors | Mutation | Phosphates | Energy metabolism | Transcription factors | Genetic disorders | Bioenergetics | Physiological aspects | Genetic aspects | Health aspects | Energetics and Metabolism
Journal Article
Blood, ISSN 0006-4971, 04/2010, Volume 115, Issue 14, pp. 2891 - 2900
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 07/2007, Volume 117, Issue 7, pp. 1926 - 1932
Journal Article